Key result
Studying disease-relevant human tissues is necessary to translate experimental evidence of vascular redox stress into personalized therapies for small-vessel disorders and hypertension.
Highlights the need to translate experimental findings on vascular redox stress to human tissues to develop targeted therapies for hypertensive small-vessel disorders.
Although convincing experimental evidence demonstrates the importance of vascular reactive oxygen and nitrogen species (RONS), oxidative stress, and perturbed redox signaling as causative processes in the vasculopathy of hypertension, this has not translated to the clinic. We discuss this bench-to-bedside disparity and the urgency to progress vascular redox pathobiology from experimental models to patients by studying disease-relevant human tissues. It is only through such approaches that the unambiguous role of vascular redox stress will be defined so that mechanism-based therapies in a personalized and precise manner can be developed to prevent, slow, or reverse progression of small-vessel disorders and consequent hypertension.
No takes yet. Share an insight, caveat, or question.
Touyz et al. (2017) conducted a review in Hypertension. Studying disease-relevant human tissues is necessary to translate experimental evidence of vascular redox stress into personalized therapies for small-vessel disorders and hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: